180 related articles for article (PubMed ID: 16332595)
1. The potential of proton beam radiation therapy in head and neck cancer.
Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
[TBL] [Abstract][Full Text] [Related]
2. The potential of proton beam radiation therapy in breast cancer.
Björk-Eriksson T; Glimelius B
Acta Oncol; 2005; 44(8):884-9. PubMed ID: 16332597
[TBL] [Abstract][Full Text] [Related]
3. The potential of proton beam therapy in paediatric cancer.
Björk-Eriksson T; Glimelius B
Acta Oncol; 2005; 44(8):871-5. PubMed ID: 16332594
[TBL] [Abstract][Full Text] [Related]
4. The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):881-3. PubMed ID: 16332596
[TBL] [Abstract][Full Text] [Related]
5. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
Johansson B; Ridderheim M; Glimelius B
Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
[TBL] [Abstract][Full Text] [Related]
6. The potential of proton beam radiation therapy in gastrointestinal cancer.
Ask A; Johansson B; Glimelius B
Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
[TBL] [Abstract][Full Text] [Related]
7. The potential of proton beam radiation for palliation and reirradiation.
Björk-Eriksson T; Ask A; Glimelius B
Acta Oncol; 2005; 44(8):918-20. PubMed ID: 16332602
[TBL] [Abstract][Full Text] [Related]
8. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.
Björk-Eriksson T; Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):913-7. PubMed ID: 16332601
[TBL] [Abstract][Full Text] [Related]
9. Number of patients potentially eligible for proton therapy.
Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
[TBL] [Abstract][Full Text] [Related]
10. The potential of proton beam radiation therapy in intracranial and ocular tumours.
Blomquist E; Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):862-70. PubMed ID: 16332593
[TBL] [Abstract][Full Text] [Related]
11. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
[TBL] [Abstract][Full Text] [Related]
12. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
13. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
[TBL] [Abstract][Full Text] [Related]
14. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
15. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
16. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
18. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
19. [Heavy charged particle radiotherapy--proton beam].
Ogino T
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
[TBL] [Abstract][Full Text] [Related]
20. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
Frese MC; Wilkens JJ; Huber PE; Jensen AD; Oelfke U; Taheri-Kadkhoda Z
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):80-8. PubMed ID: 20382482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
